Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial (Q43804231)
Jump to navigation
Jump to search
scientific article published on 12 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial |
scientific article published on 12 July 2013 |
Statements
1 reference
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial (English)
1 reference
William T Cefalu
1 reference
Lawrence A Leiter
1 reference
Kun-Ho Yoon
1 reference
Pablo Arias
1 reference
Leo Niskanen
1 reference
John Xie
1 reference
Dainius A Balis
1 reference
William Canovatchel
1 reference
Gary Meininger
1 reference
12 July 2013
1 reference
1 reference
Identifiers
1 reference